Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | GMNN | O75496 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.31 |
| ▸ | SHBG | P04278 | 1/20 | 0.31 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28974097 | 1.00 | TP53 (0.48) | TP53KDM4EGMNNLMNAMAPT | |
| SCHEMBL10447282 | 1.00 | TP53 (0.48) | TP53KDM4EGMNNLMNAMAPT | |
| SCHEMBL4983448 | 0.98 | TP53 (0.52) | TP53KDM4EGMNNLMNAMAPT | |
| SCHEMBL27615745 | 0.95 | — | — | |
| SCHEMBL27326008 | 0.90 | — | — | |
| SCHEMBL27627523 | 0.88 | — | — | |
| SCHEMBL4683222 | 0.80 | CPN1 (0.36) | TP53SLC6A3 | |
| SCHEMBL4683701 | 0.78 | CPN1 (0.42) | TP53KDM4ELMNAMAPTSMN1; SMN2 | |
| SCHEMBL15195460 | 0.74 | TP53 (0.52) | TP53KDM4EGMNNLMNAMAPT | |
| SCHEMBL9580015 | 0.74 | TP53 (0.52) | TP53KDM4EGMNNLMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107674026-A | Luso replaces Buddhist nun's intermediate（3R) the preparation method of 3 (base of 4 bromine 1H pyrazoles 1) pentamethylene base propionitrile | 厦门海乐景生化有限公司 | 2018-02-09 | — | — | CN | claimed |
| CN-115850115-B | Ruxolitinib intermediate and preparation method thereof | 上海药坦药物研究开发有限公司 | 2023-08-01 | — | — | CN | disclosed |
| CN-115850115-A | Ruxolitinib intermediate and preparation method thereof | 上海药坦药物研究开发有限公司 | 2023-03-28 | — | — | CN | disclosed |
| CN-112852768-B | Carbonyl reductase mutant and application thereof | 中国科学院天津工业生物技术研究所 | 2021-10-08 | — | — | CN | disclosed |
| CN-112852768-A | Carbonyl reductase mutant and application thereof | 中国科学院天津工业生物技术研究所 | 2021-05-28 | — | — | CN | disclosed |
| CN-107674026-B | Preparation method of ruxolitinib intermediate (3R) -3- (4-bromo-1H-pyrazol-1-yl) -cyclopentyl propionitrile | Haihua Life (Xiamen) Technology Co., Ltd. (CN) | 2019-12-06 | — | — | CN | disclosed |
| CN-107674026-A | Luso replaces Buddhist nun's intermediate（3R) the preparation method of 3 (base of 4 bromine 1H pyrazoles 1) pentamethylene base propionitrile | 厦门海乐景生化有限公司 | 2018-02-09 | — | — | CN | disclosed |
| CN-104496904-B | Synthesis method of ruxolitinib intermediate | 上海北卡医药技术有限公司 | 2017-01-11 | — | — | CN | disclosed |
| CN-104496904-B | Synthesis method of ruxolitinib intermediate | 上海北卡医药技术有限公司 | 2017-01-11 | — | — | CN | disclosed |
| CN-104496904-A | Synthesis method of ruxolitinib intermediate | BIOCOMPOUNDS PHARMACEUTICAL INC | 2015-04-08 | — | — | CN | disclosed |